-
1.
公开(公告)号:US07109044B1
公开(公告)日:2006-09-19
申请号:US09786503
申请日:1999-04-09
申请人: Hiroshi Oda , Kosuke Seiki , Hiroshi Nakajima , Nobuyuki Sato , Yoshihiro Urade , Nobuhito Hirawa , Yoshio Uehara
发明人: Hiroshi Oda , Kosuke Seiki , Hiroshi Nakajima , Nobuyuki Sato , Yoshihiro Urade , Nobuhito Hirawa , Yoshio Uehara
IPC分类号: G01N33/53
CPC分类号: G01N33/6893 , G01N33/573 , G01N33/70 , G01N33/88 , G01N2800/347 , Y10S436/811
摘要: The present invention relates to a method of detection of an early-stage renal disease, comprising determining the concentration of human lipocalin-type prostaglandin D synthase in a body fluid sample taken from a subject and comparing the determined concentration with a reference value set by determining the concentrations of human lipocalin-type prostaglandin D synthase in body fluid samples taken from healthy subjects; and a method of disease state management for a renal disease, comprising determining the concentration of human lipocalin-type prostaglandin D synthase in a body fluid sample taken from a subject and evaluating the glomerular filtration ability of the subject from the determined concentration.
摘要翻译: 本发明涉及一种早期肾病的检测方法,包括测定取自受试者的体液样品中人脂笼蛋白型前列腺素D合成酶的浓度,并将测定的浓度与通过确定 来自健康受试者的体液样品中人脂笼蛋白型前列腺素D合成酶的浓度; 以及肾病疾病状态管理方法,包括测定取自对象的体液样品中人脂质运载蛋白型前列腺素D合成酶的浓度,并根据测定的浓度评价受试者的肾小球滤过能力。
-
公开(公告)号:US06790635B1
公开(公告)日:2004-09-14
申请号:US09914319
申请日:2001-08-24
申请人: Kosuke Seiki , Hiroshi Oda , Hiroshi Nakajima , Nobuyuki Sato , Yoshihiro Urade , Yoshio Uehara , Teruo Inoue
发明人: Kosuke Seiki , Hiroshi Oda , Hiroshi Nakajima , Nobuyuki Sato , Yoshihiro Urade , Yoshio Uehara , Teruo Inoue
IPC分类号: C12Q126
CPC分类号: C12Q1/25 , G01N33/573 , G01N2333/9015
摘要: The present invention provides a method for predicting restenosis following coronary intervention by measuring human lipocalin-type prostaglandin D synthase (L-PGDS) in a body fluid sample. More particularly, this method comprises measuring the L-PGDS concentration in the sample and predicting restenosis following coronary intervention by using a change therein as an indicator.
摘要翻译: 本发明提供一种通过测量体液样品中的人脂质运载蛋白型前列腺素D合成酶(L-PGDS)来预测冠状动脉介入后再狭窄的方法。 更具体地,该方法包括测量样品中的L-PGDS浓度并且通过使用其中的改变作为指标来预测冠状动脉介入后的再狭窄。
-
公开(公告)号:US4182580A
公开(公告)日:1980-01-08
申请号:US887746
申请日:1978-03-17
申请人: Shozo Hieda , Yoshio Uehara , Minoru Inaba
发明人: Shozo Hieda , Yoshio Uehara , Minoru Inaba
CPC分类号: E02B11/005
摘要: An underdrainage pipe comprises a liquid-collecting pipe, protrusions on the liquid-collecting pipe, a filter layer around the liquid-collecting pipe and a liquid-conducting way, and the protrusions having at least one recess for each and the bottom portion of the recess not reaching the surface of the liquid-collecting pipe.
摘要翻译: 排液管包括液体收集管,集液管上的突起,集液管周围的过滤层和导液方式,并且突起具有用于每个和底部的至少一个凹部 凹部未到达集液管的表面。
-
4.
公开(公告)号:US08569261B2
公开(公告)日:2013-10-29
申请号:US13219969
申请日:2011-08-29
申请人: Itsuki Murota , Yoshio Uehara
发明人: Itsuki Murota , Yoshio Uehara
IPC分类号: A61K31/715
CPC分类号: A61K31/702 , A61K31/7016 , C12P19/00 , C12R1/38
摘要: This invention provides a vascular protecting agent having salt-absorption inhibitory activity with the use of alginate oligosaccharide salt absorbed by the body via degradation to an oligosaccharide, so that a patient can easily and safely ingest such agent on a routine basis. A vascular protecting agent having salt-absorption inhibitory activity comprises, as an active ingredient, alginate oligosaccharide obtained by treating sodium alginate with a Pseudoalteromonas microorganism or a processed product thereof and/or a salt thereof.
摘要翻译: 本发明提供一种具有吸收抑制活性的血管保护剂,其使用通过降解寡糖而被身体吸收的藻酸盐寡糖盐,使得患者可以以常规方式容易且安全地摄取该药剂。 具有盐吸收抑制活性的血管保护剂包含作为活性成分的藻酸钠寡糖,其通过用假微生物微生物或其加工产物和/或其盐处理海藻酸钠而获得。
-
5.
公开(公告)号:US20120058967A1
公开(公告)日:2012-03-08
申请号:US13219969
申请日:2011-08-29
申请人: Itsuki MUROTA , Yoshio Uehara
发明人: Itsuki MUROTA , Yoshio Uehara
IPC分类号: A61K31/715 , A61P13/12 , A61P9/00
CPC分类号: A61K31/702 , A61K31/7016 , C12P19/00 , C12R1/38
摘要: This invention provides a vascular protecting agent having salt-absorption inhibitory activity with the use of alginate oligosaccharide salt absorbed by the body via degradation to an oligosaccharide, so that a patient can easily and safely ingest such agent on a routine basis. A vascular protecting agent having salt-absorption inhibitory activity comprises, as an active ingredient, alginate oligosaccharide obtained by treating sodium alginate with a Pseudoalteromonas microorganism or a processed product thereof and/or a salt thereof.
摘要翻译: 本发明提供一种具有吸收抑制活性的血管保护剂,其使用通过降解寡糖而被身体吸收的藻酸盐寡糖盐,使得患者可以以常规方式容易且安全地摄取该药剂。 具有盐吸收抑制活性的血管保护剂包含作为活性成分的藻酸钠寡糖,其通过用假微生物微生物或其加工产物和/或其盐处理海藻酸钠而获得。
-
公开(公告)号:US4182581A
公开(公告)日:1980-01-08
申请号:US887608
申请日:1978-03-17
申请人: Yoshio Uehara , Minoru Inaba , Noriyuki Ishii , Yoshihisa Kusumi
发明人: Yoshio Uehara , Minoru Inaba , Noriyuki Ishii , Yoshihisa Kusumi
CPC分类号: E02B11/005
摘要: A pipe for underdrainage comprises (1) a liquid-collecting pipe; (2) a plurality of discontinuous protrusions on the outer surface of the liquid-collecting pipe; (3) a filter layer capable of passing liquid while substantially excluding solids, the filter layer being disposed around the liquid-collecting pipe and contacting the top portions of the protrusions; and (4) a liquid-conducting way composed of a space communicating both in the longitudinal direction and in the peripheral direction of the liquid collecting pipe and defined by the protrusions, the outer surface of the liquid-collecting pipe and the inner surface of the filter layer.
摘要翻译: 用于排污的管道包括(1)集液管; (2)在集液管的外表面上的多个不连续突起; (3)能够在基本上排除固体的同时通过液体的过滤层,所述过滤层设置在所述集液管周围并与所述突起的顶部接触; 和(4)由液体收集管的纵向方向和周向连通且由突出部限定的空间,集液管的外表面和液体收集管的内表面构成的导液方式 过滤层。
-
-
-
-
-